EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Early and longitudinal response to sublingual immunotherapy across pediatric allergic multimorbidity patterns: A 3‐year real‐world cohort study

Victor Gonzalez-Uribe iD, Jimena Prieto-Gomez iD, Sebastian Moreno-Castro iD, Ricardo Martinez-Tenopala iD, Maria Julia Rendon-Salazar iD, Tamara Hernandez-Hernandez iD, Zaira Selene Mojica-Gonzalez iD, Paola de Baro-Alvarez iD

Pediatric Allergy and Immunology · 2026-08 · 37 (8)

DOI: 10.1111/pai.70462 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 14.08.2026. Verfasst von Victor Gonzalez-Uribe und 7 weiteren Autor:innen. Beteiligte Einrichtung: AlergiaMx, Mexico City, Mexico. Hauptthemen laut MEDLINE: Sublingual Immunotherapy, Asthma, Rhinitis, Allergic, Hypersensitivity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The timing of clinically meaningful benefit after pediatric sublingual immunotherapy (SLIT) across allergic multimorbidity patterns remains uncertain. We evaluated early and longitudinal response to SLIT in routine care.

Methods

This retrospective longitudinal cohort included patients aged 3–17 years who received individualized liquid‐drop SLIT and met prespecified adherence and treatment‐persistence criteria. Assessments were performed at baseline and months 6, 12, 18, 24, and 36. The primary outcome was achievement of the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) minimal clinically important difference (MCID; increase ≥0.5 points) at month 6.

Results

Among 1208 patients, 1095 had asthma and 954 allergic rhinitis. Overall, 666/1095 (60.8%) achieved month‐6 PAQLQ MCID: 515/671 (76.8%) with asthma plus allergic rhinitis (Asthma+AR), 103/254 (40.6%) with allergic asthma without AR, and 48/170 (28.2%) with asthma, AR, and atopic dermatitis (Asthma+AR + AD). Compared with allergic asthma without AR, adjusted odds of response were higher for Asthma+AR (adjusted odds ratio 4.73, 95% CI 3.47–6.45) and lower for Asthma+AR + AD (0.52, 95% CI 0.34–0.80). By month 36, mean PAQLQ increased by 1.42 points, rhinitis‐related quality‐of‐life scores decreased by 1.89 points, FeNO decreased by 15.7 ppb, and prescribed inhaled corticosteroid dose decreased by 92.6%.

Conclusion

Early response to pediatric SLIT differed across clinical allergic multimorbidity patterns, although outcomes continued to improve through 36 months in this selected adherent and treatment‐persistent cohort. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sublingual ImmunotherapyAsthmaRhinitis, AllergicHypersensitivityHumansChildChild, PreschoolMaleFemaleAdolescentLongitudinal StudiesQuality of LifeRetrospective StudiesTreatment OutcomeMultimorbidityAllergens

Stichwörter der Autor:innen

allergic multimorbidityallergic rhinitisasthmachildrenquality of lifereal‐world cohortsublingual immunotherapy

Substanzen

Allergens

Autor:innen und Institutionen

  • AlergiaMx, Mexico City, Mexico.
  • Facultad Mexicana de Medicina, Universidad La Salle, Mexico City, Mexico.
  • Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
  • Hospital Ángeles Lomas, Huixquilucan, State of Mexico, Mexico.
  • Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico.

ORCID-Profile: Victor Gonzalez-Uribe, Jimena Prieto-Gomez, Sebastian Moreno-Castro, Ricardo Martinez-Tenopala, Maria Julia Rendon-Salazar, Tamara Hernandez-Hernandez, Zaira Selene Mojica-Gonzalez, Paola de Baro-Alvarez

Zitieren

APA

Gonzalez-Uribe, V., Prieto-Gomez, J., Moreno-Castro, S., Martinez-Tenopala, R., Rendon-Salazar, M. J., Hernandez-Hernandez, T., Mojica-Gonzalez, Z. S., & de Baro-Alvarez, P. (2026). Early and longitudinal response to sublingual immunotherapy across pediatric allergic multimorbidity patterns: A 3‐year real‐world cohort study. Pediatric Allergy and Immunology, 37(8). https://doi.org/10.1111/pai.70462

Vancouver

Gonzalez-Uribe V, Prieto-Gomez J, Moreno-Castro S, Martinez-Tenopala R, Rendon-Salazar MJ, Hernandez-Hernandez T, et al. Early and longitudinal response to sublingual immunotherapy across pediatric allergic multimorbidity patterns: A 3‐year real‐world cohort study. Pediatric Allergy and Immunology. 2026;37(8). doi:10.1111/pai.70462

BibTeX
@article{GonzalezUribe2026,
  author = {Gonzalez-Uribe, Victor and Prieto-Gomez, Jimena and Moreno-Castro, Sebastian and Martinez-Tenopala, Ricardo and Rendon-Salazar, Maria Julia and Hernandez-Hernandez, Tamara and Mojica-Gonzalez, Zaira Selene and de Baro-Alvarez, Paola},
  title = {Early and longitudinal response to sublingual immunotherapy across pediatric allergic multimorbidity patterns: A 3‐year real‐world cohort study},
  journal = {Pediatric Allergy and Immunology},
  year = {2026},
  volume = {37},
  number = {8},
  doi = {10.1111/pai.70462}
}
Kostenlos starten →